Use of Beta‐Blockers and Risk of Contralateral Breast Cancer
There has been some speculation that beta-blockers possess anti-cancer properties. Hence, researchers endeavored to retrieve...
The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
Use of Beta‐Blockers and Risk of Contralateral Breast Cancer
A Novel Treatment For Platinum-Resistant Ovarian Cancer
Racial Disparities in Non-Recommendation of Adjuvant Chemotherapy in Ovarian Cancer
Overall Survival and Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
Why Black Women with Ovarian Cancer Require Greater Focus
Ovarian Cancer Update
4 in 10 Fractures in Breast Cancer Patients Are Pathologic
Certain Cancers Increase Stroke Risk, New Analysis Confirms
Sugary Food and Beverage Consumption and the Risk of Developing Ovarian Cancer
Body Mass Index and Risk of Second Cancer Among Women with Breast Cancer
Women's Cancer Research Foundation Welcomes New Board Member
Obesity and Cancer Death Among White and Black Adults
The Importance of Observation
Chemo Brain Is Real
Research Breakthrough Could Protect Against Breast Cancer Progression
Clinical Complications of Chemotherapy and Patient-Reported Outcomes After Breast Reconstruction
Aging Cancer Survivors Have Greater Functional Decline
Artificial Intelligence and Mammography
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%